Arcutis Biotherapeutics Announces Pricing of Public : compar

WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), an early commercial-stage...

Related Keywords

New York , United States , Edgewood , Amanda Sheldon , Morgan Stanley , Broadridge Financial Solutions , Equity Syndicate Department , Guggenheim Securities , Nasdaq , Exchange Commission , Prospectus Department , Head Of Corporate Communications , Morgan Stanley Co , Arcutis Biotherapeutics Inc , Mizuho Securities , Island Avenue , Nasdaq Arqt , Arcutis Biotherapeutics , Nc , Arqt , Arcutis , Financing ,